Epidermal differentiation characteristics of the psoriatic plaque during treatment with calcipotriol
Treatment of psoriasis with vitamin D3 analogues is well established in present dermatological practice. One of the clinical sings of the psoriatic plaque that reduces early and markedly during treatment with the vitamin D3 analogue calcipotriol is scaling. Since scaling is the clinical manifestation of disordered epidermal differentiation, early changes in immunohistochemical markers for differentiation (transglutaminase, involucrin and filaggrin) were studied in patients who had been treated with calcipotriol for 4 weeks. Markers for proliferation (Ki-67 antigen) and inflammation (polymorphomuclear leucocytes and T lymphocytes) were also studied and correlated with the differentiation characteristics. Clinically, a major improvement was seen in all patients. A significant decrease in the percentage of transglutaminase-positive cell layers was observed during the first week of treatment. In contrast, an increase in transglutaminase activity in epidermal cell cultures following incubation with calcipotriol has been reported. Involucrin expression was only slightly modulated in vivo. However, a major restoration of the filaggrin-positive cell layer and significant reduction in the recruitment of cycling epidermal cells characterized the epidermal response to calcipotriol treatment. Markers for inflammation (T11-positive cells and elastase-positive cells) were also reduced substantially during the first week of treatment with calcipotriol. From this study it may be concluded that inhibition of epidermal growth and recovery of the filaggrin-positive cell layer are among the in vivo effects of calcipotriol.
Key wordsImmunohistochemistry Psoriasis Calcipotriol Epidermal differentiation
Unable to display preview. Download preview PDF.
- 14.Synkowski D, Provost T (1982) Enumeration of T-cell subhopulations in lupus erythematosus lesions using monoclonal anti-bodies. Clin Res 30:611AGoogle Scholar
- 15.Vleuten CJ van der, Kroot EJ, Jong EM de, Kerkhof PC van de (1996) The immunohistochemical effects of a single challenge with intermediate dose ultraviolet B on normal human skin. Arch Dermatol Res (in press)Google Scholar
- 19.Holland DB, Roberts SG, Russell A et al. (1990) Changes in epidermal keratin levels during treatment of psoriasis with the topical vitamin D3 analogue MC903. (abstract). Br J Dermatol 122:284Google Scholar
- 20.Verburgh CA, Nieboer C (1989) Local application of vitamin D3 pderivative MC903 in psoriasis: influence on cellular infiltrate, Langerhans cells and keratinocyte markers (abstract). J Invest Dermatol 93:310Google Scholar
- 33.Gerritsen MJ, Elbers M, Jong EM de, Kerkhof PC van de (1996) Recruitment of cycling epidermal cells and expression of filaggrin, involucrin and tenascin in the margin of the active psoriatic plaque, in the uninvolved skin of psoriatic patients and in the normal healthy skin. J Dermatol (in press)Google Scholar